FDA inspection
InvaGen Pharmaceuticals, Inc.: FDA inspection ending Jul 17, 2026
FDA inspection 1326794 · Voluntary Action Indicated (VAI) · Central Islip, NY
Key facts
| Inspection ID | 1326794 |
|---|---|
| Firm | InvaGen Pharmaceuticals, Inc. |
| FEI number | 3012696190 |
| City | Central Islip |
| State | NY |
| ZIP | 11722 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jul 17, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data